Tamer İnal

708 total citations
31 papers, 520 citations indexed

About

Tamer İnal is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tamer İnal has authored 31 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tamer İnal's work include Clinical Laboratory Practices and Quality Control (6 papers), Meta-analysis and systematic reviews (5 papers) and Quality and Safety in Healthcare (4 papers). Tamer İnal is often cited by papers focused on Clinical Laboratory Practices and Quality Control (6 papers), Meta-analysis and systematic reviews (5 papers) and Quality and Safety in Healthcare (4 papers). Tamer İnal collaborates with scholars based in Türkiye, Germany and United States. Tamer İnal's co-authors include Sali̇h Çeti̇ner, Mustafa Serteser, İbrahim Ünsal, Abdurrahman Coşkun, Osman Demırhan, İsmail Günay, Yaşar Sertdemır, Aysel Özpınar, Özlem Görüroğlu Öztürk and Akgün Yaman and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinica Chimica Acta.

In The Last Decade

Tamer İnal

29 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamer İnal Türkiye 14 150 70 68 62 58 31 520
Kali Makedou Greece 16 162 1.1× 79 1.1× 63 0.9× 77 1.2× 69 1.2× 73 616
Chunlei Li China 10 187 1.2× 86 1.2× 59 0.9× 30 0.5× 40 0.7× 15 509
Tong Chen China 15 150 1.0× 120 1.7× 80 1.2× 42 0.7× 87 1.5× 54 692
Claudia Borza Romania 12 95 0.6× 144 2.1× 82 1.2× 32 0.5× 80 1.4× 50 558
Maria G. Stathopoulou France 17 133 0.9× 183 2.6× 66 1.0× 51 0.8× 72 1.2× 54 680
Besim Prnjavorac Bosnia and Herzegovina 12 95 0.6× 125 1.8× 31 0.5× 53 0.9× 57 1.0× 57 555
Patricia Sosa Spain 13 256 1.7× 123 1.8× 45 0.7× 54 0.9× 32 0.6× 30 564
J.A. Lockton United Kingdom 11 90 0.6× 98 1.4× 49 0.7× 61 1.0× 37 0.6× 14 458
Omar Jamal Australia 15 174 1.2× 162 2.3× 84 1.2× 46 0.7× 44 0.8× 22 663
Koichiro Ina Japan 9 138 0.9× 86 1.2× 90 1.3× 19 0.3× 46 0.8× 14 414

Countries citing papers authored by Tamer İnal

Since Specialization
Citations

This map shows the geographic impact of Tamer İnal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer İnal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer İnal more than expected).

Fields of papers citing papers by Tamer İnal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamer İnal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer İnal. The network helps show where Tamer İnal may publish in the future.

Co-authorship network of co-authors of Tamer İnal

This figure shows the co-authorship network connecting the top 25 collaborators of Tamer İnal. A scholar is included among the top collaborators of Tamer İnal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamer İnal. Tamer İnal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydemir, Duygu, et al.. (2021). COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. Nucleosides Nucleotides & Nucleic Acids. 40(5). 505–517. 18 indexed citations
2.
Serdar, Muhittin A., Mehmet Şeneş, Dildar Konukoğlu, et al.. (2019). National External Quality Assessment follow-up: 2010–2017 Turkish experience. Turkish Journal of Biochemistry. 44(1). 1–8. 3 indexed citations
3.
İnal, Tamer, et al.. (2017). Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times. Journal of Clinical Laboratory Analysis. 32(1). 66 indexed citations
4.
Öztürk, Özlem Görüroğlu, et al.. (2016). Biological Variation and Reference Change Value Data for Serum Neuron‐Specific Enolase in a Turkish Population. Journal of Clinical Laboratory Analysis. 30(6). 1081–1085. 6 indexed citations
5.
Açıkalın, Ayça, et al.. (2016). Çukurova Bölgesinde D vitamini düzeyleri. SHILAP Revista de lepidopterología. 42(2). 1–1. 3 indexed citations
6.
Özpınar, Aysel, Fahrettin Keleştimur, Yıldıran Songür, et al.. (2014). Iodine Status in Turkish Populations and Exposure to Iodide Uptake Inhibitors. PLoS ONE. 9(2). e88206–e88206. 21 indexed citations
7.
Coşkun, Abdurrahman, et al.. (2012). Reference interval of pregnancy-associated plasma protein-A in healthy men and non-pregnant women. Journal of Cardiology. 61(2). 128–131. 10 indexed citations
8.
Balal, Mustafa, Saime Paydaş, Tamer İnal, et al.. (2010). Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol in renal transplant recipients. Renal Failure. 32(4). 455–458. 4 indexed citations
9.
İnal, Tamer, Mustafa Serteser, Abdurrahman Coşkun, Aysel Özpınar, & İbrahim Ünsal. (2010). Indirect Reference Intervals Estimated from Hospitalized Population for Thyrotropin and Free Thyroxine. Croatian Medical Journal. 51(2). 124–130. 29 indexed citations
10.
Çeti̇ner, Sali̇h, et al.. (2010). Analysis of peripheral blood T‐cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. International Journal of Immunogenetics. 37(4). 233–237. 59 indexed citations
11.
İnal, Tamer, et al.. (2009). What is Six Sigma. 18(2). 132–139. 1 indexed citations
12.
Köse, Fatih, Ali Ayberk Beşen, Saime Paydaş, et al.. (2009). Effects of selective Cox-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal Cox-2 expression in rats. Clinical and Experimental Nephrology. 14(1). 22–27. 6 indexed citations
13.
İnal, Tamer. (2009). Joint Commission International Accreditation for Clinical Laboratories: Monitor, analyze and improve. Clinical Biochemistry. 42(4-5). 303–303. 2 indexed citations
14.
Mert, Tufan, İsmail Günay, Ali İrfan Güzel, et al.. (2009). Macrophage depletion delays progression of neuropathic pain in diabetic animals. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(5). 445–452. 58 indexed citations
15.
Beşen, Ali Ayberk, Fatih Köse, Saime Paydaş, et al.. (2008). The effects of the nonsteroidal anti-inflammatory drug diclofenac sodium on the rat kidney, and alteration by furosemide. International Urology and Nephrology. 41(4). 919–926. 20 indexed citations
16.
Ayaz, Lokman, et al.. (2008). The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats. Cell Biochemistry and Function. 26(4). 478–485. 20 indexed citations
17.
Karataş, Yusuf, et al.. (2005). Protective Effect of <i>L</i>-Arginine Intake on the Impaired Renal Vascular Responses in the Gentamicin-Treated Rats. Nephron Physiology. 100(2). p13–p20. 26 indexed citations
18.
Acartürk, Esmeray, et al.. (2005). eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey. Clinica Chimica Acta. 354(1-2). 153–158. 36 indexed citations
19.
Canataroğlu, Abdullah, Kahraman Tanrıverdi, Tamer İnal, et al.. (2003). Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh�et's disease. Rheumatology International. 23(5). 236–240. 30 indexed citations
20.
İnal, Tamer, Abdullah Tuli, & Guneş T. Yüreğir. (1996). Evaluation of reference values for erythrocyte glutathione. Clinica Chimica Acta. 256(2). 189–196. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026